Document is current

Article History

Received: 11 October 2024

Accepted: 19 December 2024

First Online: 12 February 2025

Declarations

:

: Giancarlo Comi received consulting and speaking fees from Novartis, Sanofi, Janssen, Bristol Myers Squibb, Roche, Celltrion, Rewind. Paola Zaratin, Óscar Fernández and Per Soelberg Sørensen had nothing to disclose. Paola Zaratin declared that no conflicts of interest undergo in this publication. Óscar Fernández and Per Soelberg Sørensen declared that no conflicts of interest undergo in this publication. Paola Zaratin and Per Soelberg Sørensen are editorial board members of neurology and therapy. Paola Zaratin, Óscar Fernández and Per Soelberg Sørensen were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Representatives from pharma companies within the global proms initiative attend meetings and events related to the initiative as per their volunteering actions, thus no economic and financial reimbursements was provided for the purpose of this manuscript.

: We hereby declare that no human or animal subjects were involved in the research reported in this manuscript and the studies reported in the manuscript did not need any ethical committee approval as per their observational nature.